CGON – cg oncology, inc. (US:NASDAQ)
Stock Stats
News
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual Meeting [Yahoo! Finance]
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual Meeting
CG Oncology Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
CG Oncology, Inc. (NASDAQ: CGON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates
Form SC 13G/A CG Oncology, Inc. Filed by: VANGUARD GROUP INC
Form 10-Q CG Oncology, Inc. For: Sep 30
Form 8-K CG Oncology, Inc. For: Nov 12
Form SC 13G CG Oncology, Inc. Filed by: BlackRock, Inc.
Form SC 13G/A CG Oncology, Inc. Filed by: VANGUARD GROUP INC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.